Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels

Journal of Hepatology

Volumn 33, Issue 4, 2000, Pages 640-647

  Kronenberger, Bernd ^a   Rüster, Brigitte ^a   Lee, Jung Hun ^a   Sarrazin, Christoph ^a   Roth, W Kurt ^b   Herrmann, Günter ^a   Zeuzem, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Blutspendedienst Hessen   (Germany)

Author keywords

Apoptosis; Chronic hepatitis C; Hepatocyte proliferation; Necrosis; Persistently normal aminotransferases

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKERATIN 18; MONOCLONAL ANTIBODY KI 67; MONOCLONAL ANTIBODY M30; UNCLASSIFIED DRUG;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MALE; PRIORITY JOURNAL;

EID: 0033789375     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80017-3     Document Type: Article

References (42)

1. Increased frequency of HLA DR 13 in hepatitis C virus carriers with persistently normal ALT levels
2. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
3. Hepatitis C: The clinical spectrum of disease
4. Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with persistently normal aminotransferase levels
5. Therapy of hepatitis C: Patients with normal aminotransferase levels
6. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction
7. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
8. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels
9. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease
10. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity
11. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies
12. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels
13. Cell death by apoptosis: Basic concepts and disease relevance for the gastroenterologist
14. Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript
15. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology
16. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays
17. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
18. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
19. Ki-67 expression during rat liver regeneration after partial hepatectomy
20. Kinetic aspects of Ki-67 antigen expression in a normal cell line
21. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells
22. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxidation
23. Macrophage recognition of ICAM-3 on apoptotic leukocytes
24. Macrophage populations and apoptotic cells in the liver before spontaneous hepatitis in Long-Evans Cinnamon (LEC) rats
25. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
26. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
27. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy
28. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
29. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
30. Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover
31. Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis
32. Essential roles of the Fas ligand in the development of hepatitis
33. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor beta I in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation
34. The role of apoptosis in patients with chronic HCV and persistently normal ALT-levels
35. Necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis
36. Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases
37. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats
38. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis
39. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis
40. Caspases: Enemies within
41. Viral dynamics in hepatitis B virus infection
42. Dynamics of hepatitis B virus infection in vivo